دورية أكاديمية
Pediatric hospital utilization for patients with avoidant restrictive food intake disorder.
| العنوان: | Pediatric hospital utilization for patients with avoidant restrictive food intake disorder. |
|---|---|
| المؤلفون: | Milliren CE; Institutional Centers for Clinical and Translational Research, Boston Children's Hospital, 300 Longwood Avenue, Boston, MA, 02115, USA. carly.milliren@childrens.harvard.edu., Crowley M; Division of Gastroenterology, Hepatology, and Nutrition, Boston Children's Hospital, Boston, MA, USA.; Department of Pediatrics, Harvard Medical School, Boston, MA, USA., Carmody JK; Division of Gastroenterology, Hepatology, and Nutrition, Boston Children's Hospital, Boston, MA, USA.; Department of Psychiatry, Harvard Medical School, Boston, MA, USA., Bern EM; Division of Gastroenterology, Hepatology, and Nutrition, Boston Children's Hospital, Boston, MA, USA.; Department of Pediatrics, Harvard Medical School, Boston, MA, USA., Eldredge O; Division of Gastroenterology, Hepatology, and Nutrition, Boston Children's Hospital, Boston, MA, USA., Richmond TK; Department of Pediatrics, Harvard Medical School, Boston, MA, USA.; Division of Adolescent and Young Adult Medicine, Boston Children's Hospital, Boston, MA, USA. |
| المصدر: | Journal of eating disorders [J Eat Disord] 2024 Mar 25; Vol. 12 (1), pp. 42. Date of Electronic Publication: 2024 Mar 25. |
| نوع المنشور: | Journal Article |
| اللغة: | English |
| بيانات الدورية: | Publisher: BioMed Central Country of Publication: England NLM ID: 101610672 Publication Model: Electronic Cited Medium: Print ISSN: 2050-2974 (Print) Linking ISSN: 20502974 NLM ISO Abbreviation: J Eat Disord Subsets: PubMed not MEDLINE |
| أسماء مطبوعة: | Original Publication: London : BioMed Central, 2013- |
| مستخلص: | Background: Avoidant restrictive food intake disorder (ARFID) is a relatively new feeding and eating disorder added to the DSM-5 in 2013 and ICD-10 in 2018. Few studies have examined hospital utilization for patients with ARFID specifically, and none to date have used large administrative cohorts. We examined inpatient admission volume over time and hospital utilization and 30-day readmissions for patients with ARFID at pediatric hospitals in the United States. Methods: Using data from the Pediatric Health Information System (PHIS), we identified inpatient admissions for patients with ARFID (by principal International Classification of Diseases, 10th Revision, ICD-10 diagnosis code) discharged October 2017-June 2022. We examined the change over time in ARFID volume and associations between patient-level factors (e.g., sociodemographic characteristics, co-morbid conditions including anxiety and depressive disorders and malnutrition), hospital ARFID volume, and hospital utilization including length of stay (LOS), costs, use of enteral tube feeding or GI imaging during admission, and 30-day readmissions. Adjusted regression models were used to examine associations between sociodemographic and clinical factors on LOS, costs, and 30-day readmissions. Results: Inpatient ARFID volume across n = 44 pediatric hospitals has increased over time (β = 0.36 per month; 95% CI 0.26-0.46; p < 0.001). Among N = 1288 inpatient admissions for patients with ARFID, median LOS was 7 days (IQR = 8) with median costs of $16,583 (IQR = $18,115). LOS and costs were highest in hospitals with higher volumes of ARFID patients. Younger age, co-morbid conditions, enteral feeding, and GI imaging were also associated with LOS. 8.5% of patients were readmitted within 30 days. In adjusted models, there were differences in the likelihood of readmission by age, insurance, malnutrition diagnosis at index visit, and GI imaging procedures during index visit. Conclusions: Our results indicate that the volume of inpatient admissions for patients with ARFID has increased at pediatric hospitals in the U.S. since ARFID was added to ICD-10. Inpatient stays for ARFID are long and costly and associated with readmissions. It is important to identify effective and efficient treatment strategies for ARFID in the future. (© 2024. The Author(s).) |
| References: | J Pediatr Gastroenterol Nutr. 2016 Apr;62(4):658-63. (PMID: 26628445) Int J Eat Disord. 2020 Oct;53(10):1623-1635. (PMID: 33464594) J Eat Disord. 2017 Mar 1;5:7. (PMID: 28265411) J Eat Disord. 2018 Sep 26;6:22. (PMID: 30263118) Pediatrics. 2023 Jan 1;151(1):. (PMID: 36541052) Curr Psychiatry Rep. 2023 Feb;25(2):53-64. (PMID: 36640211) Patient Saf Surg. 2010 Feb 01;4(1):1. (PMID: 20205853) JAMA Pediatr. 2021 Jan 1;175(1):19-27. (PMID: 33074282) Pediatrics. 2021 Oct;148(4):. (PMID: 34244452) Int J Eat Disord. 2020 Oct;53(10):1636-1646. (PMID: 32776570) J Adolesc Health. 2013 Nov;53(5):573-8. (PMID: 23830088) Ann Intern Med. 2019 Dec 3;171(11):859-861. (PMID: 31476767) Int J Eat Disord. 2019 Apr;52(4):466-472. (PMID: 30597590) Arch Pediatr. 2019 Oct;26(7):437-441. (PMID: 31500920) J Adolesc Health. 2021 Oct;69(4):660-663. (PMID: 34266715) Hosp Pediatr. 2020 Jul;10(7):600-607. (PMID: 32591440) Int J Eat Disord. 2020 Feb;53(2):256-265. (PMID: 31702051) Arch Pediatr Adolesc Med. 2012 Dec;166(12):1155-64. (PMID: 23027409) JAMA Pediatr. 2021 Nov 1;175(11):1142-1150. (PMID: 34369987) Gastroenterol Hepatol (N Y). 2021 Nov;17(11):510-514. (PMID: 35466311) Eat Behav. 2021 Dec;43:101573. (PMID: 34619464) Int J Eat Disord. 2014 Jul;47(5):495-9. (PMID: 24343807) Int J Eat Disord. 2015 Jul;48(5):464-70. (PMID: 25142784) Front Psychiatry. 2021 Jul 16;12:680298. (PMID: 34349680) BMC Med. 2019 May 14;17(1):93. (PMID: 31084617) Clin Gastroenterol Hepatol. 2020 Aug;18(9):1995-2002.e1. (PMID: 31669056) Int J Behav Nutr Phys Act. 2017 May 5;14(1):62. (PMID: 28476160) J Pediatr. 2015 Mar;166(3):613-9.e5. (PMID: 25477164) Int J Eat Disord. 2018 Feb;51(2):170-173. (PMID: 29215749) J Acad Nutr Diet. 2016 Nov;116(11):1872. (PMID: 27788770) J Adolesc Health. 2014 Jul;55(1):49-52. (PMID: 24506978) Int J Eat Disord. 2021 Nov;54(11):1978-1988. (PMID: 34505302) Front Psychiatry. 2021 Jun 09;12:668297. (PMID: 34177659) Pediatrics. 2020 Nov;146(5):. (PMID: 33067343) J Eat Disord. 2021 Jun 4;9(1):65. (PMID: 34088342) AMIA Annu Symp Proc. 2011;2011:994-1003. (PMID: 22195159) JAMA Pediatr. 2022 Dec 1;176(12):1225-1232. (PMID: 36342721) Eat Weight Disord. 2014 Dec;19(4):455-60. (PMID: 24997544) |
| فهرسة مساهمة: | Keywords: 30-day readmissions; Avoidant restrictive food intake disorder (ARFID); Hospital utilization; Inpatient hospitalization; Pediatric hospitals Local Abstract: [plain-language-summary] Recent studies indicate that Avoidant Restrictive Food Intake Disorder (ARFID) is a complex feeding and eating disorder often diagnosed in younger children. To date, there are no large studies using administrative data to examine hospital utilization or costs among patients with ARFID. In a geographically diverse cohort of pediatric hospitals in the United States, we found inpatient admissions for ARFID have increased over time and that ARFID is associated with long, costly stays and readmissions which has important implications for identifying efficient treatment strategies. Future studies are needed to explore effective and efficient treatment strategies and prevent readmissions in this patient population. |
| تواريخ الأحداث: | Date Created: 20240326 Latest Revision: 20240328 |
| رمز التحديث: | 20240329 |
| مُعرف محوري في PubMed: | PMC10962111 |
| DOI: | 10.1186/s40337-024-00996-z |
| PMID: | 38528642 |
| قاعدة البيانات: | MEDLINE |
Find this article in full text from Springer Verlag. 
Full Text Finder | تدمد: | 2050-2974 |
|---|---|
| DOI: | 10.1186/s40337-024-00996-z |